Restoration of Ovarian Function After Orthotopic Ovarian Autotransplant and Follow-Up: A Case Report

Renuka Devi Rajkumaralal, Hemashree Rajesh, Su Ling Yu

Abstract


A 40-year-old married nulliparous female diagnosed with breast cancer was referred for fertility preservation before initiation of chemotherapy. Various options were discussed and she decided for ovarian tissue cryopreservation to avoid delay in treatment for cancer. She underwent laparoscopic left oophorectomy and the retrieved ovarian cortex was cryopreserved in liquid nitrogen. Two months after initiation of chemotherapy, her menses stopped and she started experiencing hot flushes leading to a diagnosis of premature menopause based on her hormone levels. Two years later after being certified free of malignancy, she underwent orthotopic transplant of the cryopreserved ovarian tissue into the other ovary and ovarian fossa. She resumed menstruation 3 months later and her hormone analysis showed a significant drop in follicle-stimulating hormone levels and luteinizing hormone levels and rise in estrogen levels. At this point of time, she lost interest in fertility and declined in vitro fertilization. On regular follow-up to assess her ovarian function, she reported regular monthly menses for 2 years which then started becoming irregular and less frequent. During her recent review 4 years after the transplant, her menses is less frequent once in 2 - 3 months with light flow but free of menopausal symptoms. Ovarian cryopreservation and autotransplant is usually done to restore fertility in women undergoing gonadotoxic treatment. This case shows that this procedure can also be considered for women who wish to restore hormonal function thereby alleviating menopausal symptoms and improving bone and cardiovascular health even though such benefits are yet to be proven scientifically. Careful selection of cases and adequate counselling regarding the benefits, risks, cost of the procedure, uncertainty of duration of ovarian function and multidisciplinary approach are important to optimize outcome in such patients.




J Med Cases. 2017;8(1):14-16
doi: https://doi.org/10.14740/jmc2701w


Keywords


Ovarian autotransplant; Fertility preservation; Premature menopause; Gonadotoxic chemotherapy

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.